Viewing Study NCT00130260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 7:14 PM
Study NCT ID: NCT00130260
Status: TERMINATED
Last Update Posted: 2008-01-04
First Post: 2005-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Sponsor: Nabi Biopharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module